Switch theme
Sign up to access all valuation multiples
CM Hospitalar SA is a distributor of hospital materials and medicines in the Brazilian market.
1996
n/a
LTM Revenue $2.1B
LTM EBITDA $121M
$666M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
CM Hospitalar has a last 12-month revenue (LTM) of $2.1B and a last 12-month EBITDA of $121M.
In the most recent fiscal year, CM Hospitalar achieved revenue of $2.1B and an EBITDA of -$76.7M.
CM Hospitalar expects next 12-month revenue of XXX and NTM EBITDA of XXX
See CM Hospitalar valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $2.1B | XXX | $2.1B | XXX | XXX | XXX |
| Gross Profit | $250M | XXX | $240M | XXX | XXX | XXX |
| Gross Margin | 12% | XXX | 11% | XXX | XXX | XXX |
| EBITDA | $121M | XXX | -$76.7M | XXX | XXX | XXX |
| EBITDA Margin | 6% | XXX | -4% | XXX | XXX | XXX |
| EBIT | $18.8M | XXX | -$30.8M | XXX | XXX | XXX |
| EBIT Margin | 1% | XXX | -1% | XXX | XXX | XXX |
| Net Profit | -$114M | XXX | -$260M | XXX | XXX | XXX |
| Net Margin | -5% | XXX | -12% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $612M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of August 18, 2025, CM Hospitalar's stock price is BRL 1 (or $0).
CM Hospitalar has current market cap of BRL 294M (or $54.0M), and EV of BRL 3.6B (or $666M).
See CM Hospitalar trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $666M | $54.0M | XXX | XXX | XXX | XXX | $-0.30 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of August 18, 2025, CM Hospitalar has market cap of $54.0M and EV of $666M.
CM Hospitalar's trades at 0.3x EV/Revenue multiple, and -8.7x EV/EBITDA.
Equity research analysts estimate CM Hospitalar's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
CM Hospitalar has a P/E ratio of -0.5x.
See valuation multiples for CM Hospitalar and 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $54.0M | XXX | $54.0M | XXX | XXX | XXX |
| EV (current) | $666M | XXX | $666M | XXX | XXX | XXX |
| EV/Revenue | 0.3x | XXX | 0.3x | XXX | XXX | XXX |
| EV/EBITDA | 5.5x | XXX | -8.7x | XXX | XXX | XXX |
| EV/EBIT | 35.4x | XXX | -21.6x | XXX | XXX | XXX |
| EV/Gross Profit | 2.7x | XXX | n/a | XXX | XXX | XXX |
| P/E | -0.5x | XXX | -0.2x | XXX | XXX | XXX |
| EV/FCF | 143.8x | XXX | -24.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialCM Hospitalar's last 12 month revenue growth is 4%
CM Hospitalar's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
CM Hospitalar's rule of 40 is 12% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
CM Hospitalar's rule of X is 16% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for CM Hospitalar and other 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 4% | XXX | 3% | XXX | XXX | XXX |
| EBITDA Margin | 6% | XXX | -4% | XXX | XXX | XXX |
| EBITDA Growth | 9% | XXX | -12% | XXX | XXX | XXX |
| Rule of 40 | 12% | XXX | 1% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 16% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 4% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 13% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Ansell | XXX | XXX | XXX | XXX | XXX | XXX |
| Polymed | XXX | XXX | XXX | XXX | XXX | XXX |
| Farmaceutica Remedia | XXX | XXX | XXX | XXX | XXX | XXX |
| Etropal | XXX | XXX | XXX | XXX | XXX | XXX |
| Sopharma | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
CM Hospitalar acquired XXX companies to date.
Last acquisition by CM Hospitalar was XXXXXXXX, XXXXX XXXXX XXXXXX . CM Hospitalar acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was CM Hospitalar founded? | CM Hospitalar was founded in 1996. |
| Where is CM Hospitalar headquartered? | CM Hospitalar is headquartered in Brazil. |
| Is CM Hospitalar publicy listed? | Yes, CM Hospitalar is a public company listed on BVMF. |
| What is the stock symbol of CM Hospitalar? | CM Hospitalar trades under VVEO3 ticker. |
| When did CM Hospitalar go public? | CM Hospitalar went public in 2021. |
| Who are competitors of CM Hospitalar? | Similar companies to CM Hospitalar include e.g. Ansell, Polymed, Farmaceutica Remedia, Etropal. |
| What is the current market cap of CM Hospitalar? | CM Hospitalar's current market cap is $54.0M |
| What is the current revenue of CM Hospitalar? | CM Hospitalar's last 12 months revenue is $2.1B. |
| What is the current revenue growth of CM Hospitalar? | CM Hospitalar revenue growth (NTM/LTM) is 4%. |
| What is the current EV/Revenue multiple of CM Hospitalar? | Current revenue multiple of CM Hospitalar is 0.3x. |
| Is CM Hospitalar profitable? | Yes, CM Hospitalar is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of CM Hospitalar? | CM Hospitalar's last 12 months EBITDA is $121M. |
| What is CM Hospitalar's EBITDA margin? | CM Hospitalar's last 12 months EBITDA margin is 6%. |
| What is the current EV/EBITDA multiple of CM Hospitalar? | Current EBITDA multiple of CM Hospitalar is 5.5x. |
| What is the current FCF of CM Hospitalar? | CM Hospitalar's last 12 months FCF is $4.6M. |
| What is CM Hospitalar's FCF margin? | CM Hospitalar's last 12 months FCF margin is 0%. |
| What is the current EV/FCF multiple of CM Hospitalar? | Current FCF multiple of CM Hospitalar is 143.8x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
